Professor, Radiology, University of California, San Francisco, School of Medicine

Radiology

Randall A. Hawkins, MD practices Radiology. He went to medical school at University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Doctor Randall A. Hawkins, MD is a published physician as well. He has 38 publications published. The latest was: Recovery of Native Renal Function in Patients with Hepatorenal Syndrome Following Combined Liver and Kidney Transplant with Mercaptoacetyltriglycine-3 Renogram: Develo...

Publications

---

• Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving (131) I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.
• Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With (131) I-Metaiodobenzylguanidine (MIBG).
• (131)I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Ther...
• Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma.
• Bone Remodeling after MR Imaging-guided High-Intensity Focused Ultrasound Ablation: Evaluation with MR Imaging, CT, Na(18)F-PET, and Histopathologic Examination in a S...
• Likelihood of Bone Recurrence in Prior Sites of Metastasis in Patients With High-Risk Neuroblastoma.
• (90)Y Glass Microspheres for the Treatment of Unresectable Metastatic Liver Disease from Chemotherapy-Refractory Gastrointestinal Cancers: A Pilot Study.
• Triple-Negative and Non-Triple-Negative Invasive Breast Cancer: Association between MR and Fluorine 18 Fluorodeoxyglucose PET Imaging.
• Acute Changes in Blood Pressure in Patients With Neuroblastoma Treated With (131) I-Metaiodobenzylguanidine (MIBG).
• 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
• Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
• Proteinuria in Metastatic Pheochromocytoma is Associated with an Increased Risk of Acute Respiratory Distress Syndrome, Spontaneously or After Therapy with 131I-Meta-i...
• Differentiation of Normal Thymus from Anterior Mediastinal Lymphoma and Lymphoma Recurrence at Pediatric PET/CT.
• Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology pati...
• Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
• Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
• In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
• Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
• Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
• Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
• Perineural spread of melanoma demonstrated by F-18 FDG PET With MRI and pathologic correlation.
• Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient.
• Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause.
• Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.
• Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
• Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
• Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
• Progress in SPECT/CT imaging of prostate cancer.
• Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
• Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
• Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
• Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.
• Dual-modality imaging of cancer with SPECT/CT.
• Advances in positron emission tomography imaging for the GI tract.
• Design and applications of a multimodality image data warehouse framework.
• Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma.
• Recovery of Native Renal Function in Patients with Hepatorenal Syndrome Following Combined Liver and Kidney Transplant with Mercaptoacetyltriglycine-3 Renogram: Develo...

Schools

---

• University Of California Irvine College Of Medicine

• UCLA Med Center

Doctors Specialties

---

• Diagnostic Radiology
• Nuclear Medicine
• Radiology

Accepted Insurances

---

Awards

---

• Regional Top Doctor
• CMS Meaningful Use Stage 1 Certification

Education

---

• UCLA Medical Center
• University of Southern California - LAC+USC Medical Center
• University of California Irvine School of Medicine

Hospital

---

• San Francisco VA Medical Center
• San Francisco General Hospital and Trauma Center
• UCSF Medical Center

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1073569208
Last Name Of The Provider	HAWKINS
First Name Of The Provider	RANDALL
View All

Similar Doctors

---

	Dr. Michael W. Dae, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James K. Brown, MD This Doctor is OpenDoctor Recommended.
	Dr. Vickie A. Feldstein, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles A. Gooding, MD This Doctor is OpenDoctor Recommended.
	Dr. William B. Harvey II, MD
	Dr. Jessica W. Leung, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David C. Price, MD
	Dr. John D. Rego Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Glenn M. Strome, MD This Doctor is OpenDoctor Recommended.
	Dr. Lisa L. Schmelzel, MD This Doctor is OpenDoctor Recommended.
	Dr. Michelle M. Nguyen, MD
	Dr. Raymond H. Welsh, MD This Doctor is OpenDoctor Recommended.
	Dr. Allan I. Bloom, MD This Doctor is OpenDoctor Recommended.
	Dr. Jose M. Hernandez Pampaloni, MD This Doctor is OpenDoctor Recommended.
	Dr. Marc C. Mabray, MD This Doctor is OpenDoctor Recommended.
	Dr. Leo P. Sugrue, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog